GDAP1L1: Key Regulator of Neurogenesis, Inflammation and Cellular Processes

Target Name: GDAP1L1

NCBI ID: G78997

GDAP1L1

GDAP1L1: Key Regulator of Neurogenesis, Inflammation and Cellular Processes

Ganglioside-induced differentiation associated protein 1 like 1 (GDAP1L1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of cellular processes that are important for maintaining tissue repair and regeneration.

One of the things that is known about GDAP1L1 is that it is a key regulator of the process of neurogenesis, which is the process by which new neurons are produced in the brain. This is important for tasks such as learning and memory, and it is also involved in the regulation of stress and anxiety.

In addition to its role in neurogenesis, GDAP1L1 is also involved in the regulation of inflammation and immune responses. It has been shown to be involved in the development of neuroinflammatory diseases, such as multiple sclerosis and Alzheimer's disease.

GDAP1L1 is also known to be involved in the regulation of cell death, which is an important part of the immune response. It has been shown to be involved in the regulation of programmed cell death, which is the process by which cells are killed that have reached the end of their lives.

In addition to its involvement in neurogenesis, GDAP1L1 is also thought to be involved in the regulation of a variety of cellular processes that are important for maintaining tissue health and function. This includes the regulation of cell signaling, cell adhesion, and the regulation of ion channels.

GDAP1L1 is also a potential drug target, and is being studied for its potential therapeutic uses. For example, some researchers are interested in using GDAP1L1 as a target for treating neuroinflammatory diseases, such as multiple sclerosis and Alzheimer's disease. Others are interested in using it as a target for treating stress and anxiety disorders.

Overall, GDAP1L1 is a protein that is involved in a variety of important cellular processes in the body. While more research is needed to fully understand its function and potential therapeutic uses, its potential as a drug target is an exciting area of research.

Protein Name: Ganglioside Induced Differentiation Associated Protein 1 Like 1

The "GDAP1L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GDAP1L1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets